Executive record

John P. Hamill

Senior Vice President, Chief Financial Officer and Secretary at Aprea Therapeutics, Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:justin-g-hamillVersion: public-0As of: 2026-09-29

Not yet claimed6 published Claims2 sources
  • Executive

Key Claims

Biography

Joined Aprea in January 2023 from Windtree Therapeutics where he served as SVP and CFO since 2020. Brings over 30 years of financial leadership in pharmaceutical and biopharmaceutical sectors with broad experience in financial, administrative, information technology, and facility functions.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Executive career

  1. Current · dates not publishedSenior Vice President, Chief Financial Officer and Secretary · Aprea Therapeutics, Inc.
  2. 2026 to end not publishedExecutive title: Senior Vice President, Chief Financial Officer and Secretary · Organization not publishedAPRE 10-K executive officers

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

2 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Open source

    sec def 14a · Source published: Apr 30, 2026 · Retrieved: Sep 6, 2026

    Supports 1 claim
    • Professional Role: Senior Vice President, Chief Financial Officer and Secretary at Aprea Therapeutics, Inc. · Claim reviewed: Sep 6, 2026

  2. APRE 10-K executive officers

    sec filing · Source published: Mar 16, 2026 · Retrieved: May 15, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Executive company: Executive at Aprea Therapeutics, Inc. · Claim reviewed: May 15, 2026
    • Executive title: Executive title: Senior Vice President, Chief Financial Officer and Secretary · Claim reviewed: May 15, 2026
    • Technology background: Technology background reported in filings · Claim reviewed: May 15, 2026